nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Ifosfamide—testicular cancer	0.152	0.297	CbGbCtD
Guanfacine—CYP2C9—Ifosfamide—testicular cancer	0.126	0.247	CbGbCtD
Guanfacine—CYP3A4—Ifosfamide—testicular cancer	0.0734	0.144	CbGbCtD
Guanfacine—CYP2C9—Cisplatin—testicular cancer	0.0614	0.12	CbGbCtD
Guanfacine—CYP3A4—Vinblastine—testicular cancer	0.0389	0.0762	CbGbCtD
Guanfacine—CYP3A4—Etoposide—testicular cancer	0.0351	0.0687	CbGbCtD
Guanfacine—CYP3A4—Doxorubicin—testicular cancer	0.0239	0.0468	CbGbCtD
Guanfacine—NISCH—Podofilox—Etoposide—testicular cancer	0.0101	0.539	CbGdCrCtD
Guanfacine—NISCH—Vincristine—Vinblastine—testicular cancer	0.00864	0.461	CbGdCrCtD
Guanfacine—Constipation—Ifosfamide—testicular cancer	0.000957	0.00203	CcSEcCtD
Guanfacine—Loss of consciousness—Etoposide—testicular cancer	0.000952	0.00202	CcSEcCtD
Guanfacine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000952	0.00202	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—testicular cancer	0.000952	0.00202	CcSEcCtD
Guanfacine—Tachycardia—Cisplatin—testicular cancer	0.000942	0.002	CcSEcCtD
Guanfacine—Asthenia—Bleomycin—testicular cancer	0.00094	0.002	CcSEcCtD
Guanfacine—Convulsion—Etoposide—testicular cancer	0.000938	0.00199	CcSEcCtD
Guanfacine—Hypertension—Etoposide—testicular cancer	0.000935	0.00199	CcSEcCtD
Guanfacine—Pain in extremity—Doxorubicin—testicular cancer	0.000933	0.00198	CcSEcCtD
Guanfacine—Hyperhidrosis—Cisplatin—testicular cancer	0.000933	0.00198	CcSEcCtD
Guanfacine—Asthma—Methotrexate—testicular cancer	0.000931	0.00198	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—testicular cancer	0.000931	0.00198	CcSEcCtD
Guanfacine—Pruritus—Bleomycin—testicular cancer	0.000926	0.00197	CcSEcCtD
Guanfacine—Feeling abnormal—Ifosfamide—testicular cancer	0.000922	0.00196	CcSEcCtD
Guanfacine—Chest pain—Etoposide—testicular cancer	0.000922	0.00196	CcSEcCtD
Guanfacine—Nausea—Vinblastine—testicular cancer	0.000921	0.00196	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000921	0.00196	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—testicular cancer	0.000921	0.00196	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—testicular cancer	0.000918	0.00195	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000915	0.00195	CcSEcCtD
Guanfacine—Discomfort—Etoposide—testicular cancer	0.000911	0.00194	CcSEcCtD
Guanfacine—Hypotension—Cisplatin—testicular cancer	0.000902	0.00192	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—testicular cancer	0.0009	0.00191	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—testicular cancer	0.000893	0.0019	CcSEcCtD
Guanfacine—Confusional state—Etoposide—testicular cancer	0.000891	0.00189	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000889	0.00189	CcSEcCtD
Guanfacine—Abdominal pain—Ifosfamide—testicular cancer	0.000885	0.00188	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000879	0.00187	CcSEcCtD
Guanfacine—Asthenia—Dactinomycin—testicular cancer	0.000876	0.00186	CcSEcCtD
Guanfacine—Asthma—Epirubicin—testicular cancer	0.000871	0.00185	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—testicular cancer	0.000871	0.00185	CcSEcCtD
Guanfacine—Paraesthesia—Cisplatin—testicular cancer	0.000866	0.00184	CcSEcCtD
Guanfacine—Tachycardia—Etoposide—testicular cancer	0.000863	0.00183	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—testicular cancer	0.000861	0.00183	CcSEcCtD
Guanfacine—Dyspnoea—Cisplatin—testicular cancer	0.00086	0.00183	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—testicular cancer	0.000857	0.00182	CcSEcCtD
Guanfacine—Hyperhidrosis—Etoposide—testicular cancer	0.000854	0.00182	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—testicular cancer	0.000852	0.00181	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000852	0.00181	CcSEcCtD
Guanfacine—Decreased appetite—Cisplatin—testicular cancer	0.000839	0.00178	CcSEcCtD
Guanfacine—Diarrhoea—Dactinomycin—testicular cancer	0.000836	0.00178	CcSEcCtD
Guanfacine—Vomiting—Bleomycin—testicular cancer	0.000833	0.00177	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—testicular cancer	0.00083	0.00176	CcSEcCtD
Guanfacine—Hypotension—Etoposide—testicular cancer	0.000826	0.00176	CcSEcCtD
Guanfacine—Rash—Bleomycin—testicular cancer	0.000826	0.00176	CcSEcCtD
Guanfacine—Dermatitis—Bleomycin—testicular cancer	0.000825	0.00175	CcSEcCtD
Guanfacine—Hypersensitivity—Ifosfamide—testicular cancer	0.000825	0.00175	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000823	0.00175	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—testicular cancer	0.000807	0.00172	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—testicular cancer	0.000806	0.00171	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—testicular cancer	0.000806	0.00171	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—testicular cancer	0.000805	0.00171	CcSEcCtD
Guanfacine—Asthenia—Ifosfamide—testicular cancer	0.000803	0.00171	CcSEcCtD
Guanfacine—Sweating—Methotrexate—testicular cancer	0.000796	0.00169	CcSEcCtD
Guanfacine—Feeling abnormal—Cisplatin—testicular cancer	0.000795	0.00169	CcSEcCtD
Guanfacine—Paraesthesia—Etoposide—testicular cancer	0.000794	0.00169	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—testicular cancer	0.000793	0.00169	CcSEcCtD
Guanfacine—Pruritus—Ifosfamide—testicular cancer	0.000792	0.00168	CcSEcCtD
Guanfacine—Dyspnoea—Etoposide—testicular cancer	0.000788	0.00168	CcSEcCtD
Guanfacine—Somnolence—Etoposide—testicular cancer	0.000786	0.00167	CcSEcCtD
Guanfacine—Nausea—Bleomycin—testicular cancer	0.000778	0.00165	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—testicular cancer	0.000777	0.00165	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—testicular cancer	0.000776	0.00165	CcSEcCtD
Guanfacine—Rash—Dactinomycin—testicular cancer	0.00077	0.00164	CcSEcCtD
Guanfacine—Decreased appetite—Etoposide—testicular cancer	0.000768	0.00163	CcSEcCtD
Guanfacine—Diarrhoea—Ifosfamide—testicular cancer	0.000766	0.00163	CcSEcCtD
Guanfacine—Fatigue—Etoposide—testicular cancer	0.000762	0.00162	CcSEcCtD
Guanfacine—Constipation—Etoposide—testicular cancer	0.000756	0.00161	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—testicular cancer	0.000755	0.00161	CcSEcCtD
Guanfacine—Sweating—Epirubicin—testicular cancer	0.000745	0.00158	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—testicular cancer	0.000745	0.00158	CcSEcCtD
Guanfacine—Dizziness—Ifosfamide—testicular cancer	0.00074	0.00157	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—testicular cancer	0.000734	0.00156	CcSEcCtD
Guanfacine—Feeling abnormal—Etoposide—testicular cancer	0.000728	0.00155	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—testicular cancer	0.000725	0.00154	CcSEcCtD
Guanfacine—Gastrointestinal pain—Etoposide—testicular cancer	0.000723	0.00154	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—testicular cancer	0.000719	0.00153	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—testicular cancer	0.000718	0.00153	CcSEcCtD
Guanfacine—Vomiting—Ifosfamide—testicular cancer	0.000712	0.00151	CcSEcCtD
Guanfacine—Hypersensitivity—Cisplatin—testicular cancer	0.000711	0.00151	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—testicular cancer	0.00071	0.00151	CcSEcCtD
Guanfacine—Rash—Ifosfamide—testicular cancer	0.000706	0.0015	CcSEcCtD
Guanfacine—Dermatitis—Ifosfamide—testicular cancer	0.000705	0.0015	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—testicular cancer	0.000699	0.00149	CcSEcCtD
Guanfacine—Abdominal pain—Etoposide—testicular cancer	0.000699	0.00149	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—testicular cancer	0.000699	0.00149	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—testicular cancer	0.000696	0.00148	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—testicular cancer	0.000695	0.00148	CcSEcCtD
Guanfacine—Asthenia—Cisplatin—testicular cancer	0.000692	0.00147	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—testicular cancer	0.000689	0.00146	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—testicular cancer	0.000673	0.00143	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—testicular cancer	0.000672	0.00143	CcSEcCtD
Guanfacine—Nausea—Ifosfamide—testicular cancer	0.000665	0.00141	CcSEcCtD
Guanfacine—Diarrhoea—Cisplatin—testicular cancer	0.00066	0.0014	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—testicular cancer	0.000659	0.0014	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—testicular cancer	0.000657	0.0014	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—testicular cancer	0.000652	0.00139	CcSEcCtD
Guanfacine—Hypersensitivity—Etoposide—testicular cancer	0.000651	0.00138	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—testicular cancer	0.00065	0.00138	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—testicular cancer	0.000647	0.00138	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—testicular cancer	0.000635	0.00135	CcSEcCtD
Guanfacine—Asthenia—Etoposide—testicular cancer	0.000634	0.00135	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—testicular cancer	0.00063	0.00134	CcSEcCtD
Guanfacine—Pruritus—Etoposide—testicular cancer	0.000625	0.00133	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—testicular cancer	0.000622	0.00132	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—testicular cancer	0.000616	0.00131	CcSEcCtD
Guanfacine—Vomiting—Cisplatin—testicular cancer	0.000613	0.0013	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—testicular cancer	0.000611	0.0013	CcSEcCtD
Guanfacine—Rash—Cisplatin—testicular cancer	0.000608	0.00129	CcSEcCtD
Guanfacine—Dermatitis—Cisplatin—testicular cancer	0.000608	0.00129	CcSEcCtD
Guanfacine—Diarrhoea—Etoposide—testicular cancer	0.000605	0.00129	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—testicular cancer	0.000603	0.00128	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—testicular cancer	0.000602	0.00128	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—testicular cancer	0.000602	0.00128	CcSEcCtD
Guanfacine—Tension—Epirubicin—testicular cancer	0.000596	0.00127	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—testicular cancer	0.000594	0.00126	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—testicular cancer	0.00059	0.00125	CcSEcCtD
Guanfacine—Malaise—Methotrexate—testicular cancer	0.000585	0.00124	CcSEcCtD
Guanfacine—Dizziness—Etoposide—testicular cancer	0.000584	0.00124	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—testicular cancer	0.000584	0.00124	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—testicular cancer	0.000583	0.00124	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—testicular cancer	0.000583	0.00124	CcSEcCtD
Guanfacine—Nausea—Cisplatin—testicular cancer	0.000573	0.00122	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—testicular cancer	0.000572	0.00122	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—testicular cancer	0.00057	0.00121	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—testicular cancer	0.000563	0.0012	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—testicular cancer	0.000562	0.00119	CcSEcCtD
Guanfacine—Vomiting—Etoposide—testicular cancer	0.000562	0.00119	CcSEcCtD
Guanfacine—Agitation—Epirubicin—testicular cancer	0.000558	0.00119	CcSEcCtD
Guanfacine—Rash—Etoposide—testicular cancer	0.000557	0.00118	CcSEcCtD
Guanfacine—Dermatitis—Etoposide—testicular cancer	0.000557	0.00118	CcSEcCtD
Guanfacine—Headache—Etoposide—testicular cancer	0.000554	0.00118	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—testicular cancer	0.000552	0.00117	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—testicular cancer	0.000552	0.00117	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—testicular cancer	0.000552	0.00117	CcSEcCtD
Guanfacine—Tension—Doxorubicin—testicular cancer	0.000551	0.00117	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—testicular cancer	0.00055	0.00117	CcSEcCtD
Guanfacine—Malaise—Epirubicin—testicular cancer	0.000547	0.00116	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—testicular cancer	0.000546	0.00116	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—testicular cancer	0.000546	0.00116	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—testicular cancer	0.000545	0.00116	CcSEcCtD
Guanfacine—Syncope—Epirubicin—testicular cancer	0.000544	0.00116	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—testicular cancer	0.00054	0.00115	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—testicular cancer	0.000536	0.00114	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—testicular cancer	0.000534	0.00113	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—testicular cancer	0.000534	0.00113	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—testicular cancer	0.000529	0.00113	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—testicular cancer	0.000526	0.00112	CcSEcCtD
Guanfacine—Nausea—Etoposide—testicular cancer	0.000525	0.00112	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—testicular cancer	0.000524	0.00111	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000521	0.00111	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—testicular cancer	0.000517	0.0011	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—testicular cancer	0.000517	0.0011	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—testicular cancer	0.000517	0.0011	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—testicular cancer	0.000516	0.0011	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—testicular cancer	0.000515	0.00109	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—testicular cancer	0.000512	0.00109	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—testicular cancer	0.000511	0.00109	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—testicular cancer	0.000507	0.00108	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—testicular cancer	0.000505	0.00107	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—testicular cancer	0.000505	0.00107	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—testicular cancer	0.000504	0.00107	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—testicular cancer	0.0005	0.00106	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—testicular cancer	0.000496	0.00106	CcSEcCtD
Guanfacine—Oedema—Epirubicin—testicular cancer	0.000495	0.00105	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—testicular cancer	0.000495	0.00105	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—testicular cancer	0.000494	0.00105	CcSEcCtD
Guanfacine—Shock—Epirubicin—testicular cancer	0.000487	0.00104	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—testicular cancer	0.000487	0.00103	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—testicular cancer	0.000485	0.00103	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—testicular cancer	0.000484	0.00103	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000482	0.00103	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—testicular cancer	0.000479	0.00102	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—testicular cancer	0.000479	0.00102	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—testicular cancer	0.000478	0.00102	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—testicular cancer	0.000478	0.00102	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—testicular cancer	0.000478	0.00102	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—testicular cancer	0.000477	0.00101	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—testicular cancer	0.000475	0.00101	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—testicular cancer	0.000472	0.001	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—testicular cancer	0.000472	0.001	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—testicular cancer	0.000471	0.001	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—testicular cancer	0.000468	0.000994	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—testicular cancer	0.000466	0.000991	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—testicular cancer	0.000463	0.000984	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—testicular cancer	0.000462	0.000983	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—testicular cancer	0.00046	0.000978	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—testicular cancer	0.000458	0.000975	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—testicular cancer	0.000456	0.00097	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000451	0.00096	CcSEcCtD
Guanfacine—Shock—Doxorubicin—testicular cancer	0.000451	0.000959	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—testicular cancer	0.000448	0.000953	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—testicular cancer	0.000447	0.000951	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—testicular cancer	0.000445	0.000946	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000443	0.000942	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—testicular cancer	0.000442	0.000939	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—testicular cancer	0.00044	0.000936	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—testicular cancer	0.000436	0.000927	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—testicular cancer	0.000436	0.000927	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000433	0.00092	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—testicular cancer	0.000431	0.000916	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—testicular cancer	0.000428	0.000911	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—testicular cancer	0.000427	0.000908	CcSEcCtD
Guanfacine—Constipation—Epirubicin—testicular cancer	0.000424	0.000901	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—testicular cancer	0.000419	0.00089	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000418	0.000888	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—testicular cancer	0.000415	0.000881	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—testicular cancer	0.000412	0.000875	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—testicular cancer	0.000409	0.000869	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—testicular cancer	0.000408	0.000868	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—testicular cancer	0.000408	0.000866	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000405	0.000861	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—testicular cancer	0.000404	0.000858	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—testicular cancer	0.000399	0.000847	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—testicular cancer	0.000395	0.00084	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—testicular cancer	0.000392	0.000833	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—testicular cancer	0.000392	0.000833	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—testicular cancer	0.00039	0.000829	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—testicular cancer	0.00038	0.000807	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—testicular cancer	0.000378	0.000803	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000375	0.000797	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—testicular cancer	0.000375	0.000796	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—testicular cancer	0.000365	0.000776	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—testicular cancer	0.000362	0.00077	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—testicular cancer	0.000362	0.00077	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—testicular cancer	0.000355	0.000756	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—testicular cancer	0.000351	0.000745	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—testicular cancer	0.00035	0.000744	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—testicular cancer	0.000339	0.000721	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—testicular cancer	0.000338	0.000718	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—testicular cancer	0.000337	0.000716	CcSEcCtD
Guanfacine—Rash—Methotrexate—testicular cancer	0.000334	0.00071	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—testicular cancer	0.000334	0.000709	CcSEcCtD
Guanfacine—Headache—Methotrexate—testicular cancer	0.000332	0.000705	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—testicular cancer	0.000329	0.000699	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—testicular cancer	0.000328	0.000696	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—testicular cancer	0.000324	0.000689	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—testicular cancer	0.000315	0.00067	CcSEcCtD
Guanfacine—Nausea—Methotrexate—testicular cancer	0.000314	0.000668	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—testicular cancer	0.000314	0.000667	CcSEcCtD
Guanfacine—Rash—Epirubicin—testicular cancer	0.000312	0.000664	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—testicular cancer	0.000312	0.000663	CcSEcCtD
Guanfacine—Headache—Epirubicin—testicular cancer	0.00031	0.00066	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—testicular cancer	0.000303	0.000644	CcSEcCtD
Guanfacine—Nausea—Epirubicin—testicular cancer	0.000294	0.000626	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—testicular cancer	0.000291	0.00062	CcSEcCtD
Guanfacine—Rash—Doxorubicin—testicular cancer	0.000289	0.000614	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—testicular cancer	0.000289	0.000614	CcSEcCtD
Guanfacine—Headache—Doxorubicin—testicular cancer	0.000287	0.00061	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—testicular cancer	0.000272	0.000579	CcSEcCtD
